Citigroup’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $300K | Buy |
70,331
+39,340
| +127% | +$168K | ﹤0.01% | 3168 |
|
|
2025
Q1 | $117K | Sell |
30,991
-37,005
| -54% | -$139K | ﹤0.01% | 3745 |
|
|
2024
Q4 | $396K | Buy |
67,996
+37,899
| +126% | +$221K | ﹤0.01% | 3176 |
|
|
2024
Q3 | $359K | Buy |
30,097
+6,345
| +27% | +$75.8K | ﹤0.01% | 3197 |
|
|
2024
Q2 | $257K | Sell |
23,752
-226,230
| -90% | -$2.45M | ﹤0.01% | 3049 |
|
|
2024
Q1 | $2.83M | Buy |
249,982
+245,175
| +5,100% | +$2.78M | ﹤0.01% | 1585 |
|
|
2023
Q4 | $67.4K | Buy |
4,807
+4,792
| +31,947% | +$67.2K | ﹤0.01% | 3639 |
|
|
2023
Q3 | $186 | Sell |
15
-7,979
| -100% | -$98.9K | ﹤0.01% | 4562 |
|
|
2023
Q2 | $72.2K | Sell |
7,994
-1,918
| -19% | -$17.3K | ﹤0.01% | 3741 |
|
|
2023
Q1 | $34.4K | Buy |
+9,912
| New | +$34.4K | ﹤0.01% | 3725 |
|
|
2022
Q4 | – | Sell |
-1,196
| Closed | -$3K | – | 5013 |
|
|
2022
Q3 | $3K | Sell |
1,196
-466
| -28% | -$1.17K | ﹤0.01% | 4604 |
|
|
2022
Q2 | $7K | Sell |
1,662
-6,317
| -79% | -$26.6K | ﹤0.01% | 4750 |
|
|
2022
Q1 | $34K | Sell |
7,979
-289
| -3% | -$1.23K | ﹤0.01% | 4189 |
|
|
2021
Q4 | $77K | Buy |
8,268
+5,253
| +174% | +$48.9K | ﹤0.01% | 4098 |
|
|
2021
Q3 | $83K | Buy |
3,015
+297
| +11% | +$8.18K | ﹤0.01% | 3741 |
|
|
2021
Q2 | $76K | Buy |
2,718
+1,531
| +129% | +$42.8K | ﹤0.01% | 3961 |
|
|
2021
Q1 | $39K | Sell |
1,187
-5,725
| -83% | -$188K | ﹤0.01% | 4180 |
|
|
2020
Q4 | $332K | Buy |
+6,912
| New | +$332K | ﹤0.01% | 2919 |
|